Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-15

Clinical Trial Update: Pregabalin for the Treatment of Uremic Pruritus [Phase 4]

View source ↗

Summary

Clinical trial update for pregabalin in the treatment of uremic pruritus (Phase 4). The current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Uremic Pruritus | Phase 4 | Status: UNKNOWN